Compounds > tenidap
Page last updated: 2024-08-24

tenidap and Bone Loss, Osteoclastic

tenidap has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Golub, L; Greenwald, R; Leung, M; Moak, S; Ramamurthy, N1

Other Studies

1 other study(ies) available for tenidap and Bone Loss, Osteoclastic

ArticleYear
CMT/NSAID combination increases bone CMT uptake and inhibits bone resorption.
    Annals of the New York Academy of Sciences, 1993, Nov-30, Volume: 696

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone and Bones; Bone Resorption; Drug Therapy, Combination; Indoles; Male; Matrix Metalloproteinase Inhibitors; Oxindoles; Rats; Rats, Inbred Lew; Tetracycline

1993